Diabetes Care, Vol 21, Issue 3 368-373, Copyright © 1998 by American Diabetes Association

ARTICLES

Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database

LM Pogach, G Hawley, R Weinstock, C Sawin, H Schiebe, F Cutler, F Zieve, M Bates and D Repke
Medical Service, East Orange Veterans Administration Medical Center, New Jersey 07019, USA.

OBJECTIVE: To develop a diabetes registry from an outpatient pharmacy database to systematically analyze the prevalence of diabetes, patterns of glycemic medication and glucose monitoring, pharmacy costs, and hospital use related to diabetes care in the Veterans Health Administration (VHA) in fiscal year (FY) 1994. RESEARCH DESIGN AND METHODS: Veterans with diabetes were identified using a software program that extracted the social security number (SSN) of patients receiving insulin, sulfonylurea agents, or glucose-monitoring supplies. The cumulative FY94 cost for a drug was calculated by multiplying the units dispensed times the unit cost for each fill, using the actual drug cost that was in effect at the time of dispensing. Admission data were obtained by crossmatching the SSN registry with the VHA Austin Mainframe Patient Treatment Files to retrieve associated diagnosis-related groups (DRG), Physicians' Current Procedural Terminology (CPT), and International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) codes. RESULTS: From among 1,180,260 unique patients, 139,646 veterans with diabetes receiving insulin, oral agents, or glucose-monitoring strips were identified, accounting for a prevalence of 11.83% from 62 Veterans Administration medical centers. There were 63,078 individuals (52%) who received oral agents, of whom 26.3% also received blood glucose-monitoring supplies; 46,664 individuals (39%) received insulin, of whom 53.2% received blood glucose-monitoring supplies; and 9,440 individuals (8%) received both oral agents and insulin during FY94, with 64.4% receiving blood glucose-monitoring supplies. Only 1,482 (1.2%) individuals received monitoring supplies alone, and 129 patients (0.1%) were provided with an insulin pump. Using an adjusted data set, 12% of veterans accounted for 24% of all outpatient pharmacy costs, with an average expenditure of $622 for veterans with diabetes compared with $276 for veterans without diabetes. There was $454 (73%) for non-diabetes-specific prescriptions and $168 (27%) for prescriptions related to glycemic control. Of pharmacy expenditures for glycemic control, $101 (60.1%) was attributed to insulin, oral agents, and supplies, while $67 (39.9%) was attributable to glucose monitoring. Veterans with diabetes were admitted 1.6 times as frequently as veterans without diabetes. CONCLUSIONS: This study demonstrates the feasibility of using a pharmacy-based electronic diabetes database in a payor system that can track both claims and individual classes of medication based on a unique identifier number. While the prevalence of diabetes in the VHA is high relative to other health care systems and the general population, patterns of medication usage, pharmacy costs, and relative admission frequency are comparable to results from the private sector.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Robbins and D. A. Webb Hospital Admission Rates for a Racially Diverse Low-Income Cohort of Patients With Diabetes: The Urban Diabetes Study Am J Public Health, July 1, 2006; 96(7): 1260 - 1264. [Abstract] [Full Text] [PDF]

				A. M. Kilbourne, C. B. Good, S. M. Sereika, A. C. Justice, and M. J. Fine Algorithm for assessing patients' adherence to oral hypoglycemic medication Am. J. Health Syst. Pharm., January 15, 2005; 62(2): 198 - 204. [Full Text] [PDF]

				G. E. Reiber, E. J. Boyko, C. Maynard, T. D. Koepsell, and L. M. Pogach Diabetes in the Department of Veterans Affairs Diabetes Care, May 1, 2004; 27(suppl_2): B1 - B2. [Full Text] [PDF]

				D. R. Miller, M. M. Safford, and L. M. Pogach Who Has Diabetes? Best Estimates of Diabetes Prevalence in the Department of Veterans Affairs Based on Computerized Patient Data Diabetes Care, May 1, 2004; 27(suppl_2): B10 - B21. [Abstract] [Full Text] [PDF]

				R. A. Hayward, T. P. Hofer, E. A. Kerr, and S. L. Krein Quality Improvement Initiatives: Issues in moving from diabetes guidelines to policy Diabetes Care, May 1, 2004; 27(suppl_2): B54 - B60. [Abstract] [Full Text] [PDF]

				M. L. Maciejewski and C. Maynard Diabetes-Related Utilization and Costs for Inpatient and Outpatient Services in the Veterans Administration Diabetes Care, May 1, 2004; 27(suppl_2): B69 - B73. [Abstract] [Full Text] [PDF]

				R. S. Weinstock, G. Hawley, D. Repke, B. L. Feuerstein, C. T. Sawin, and L. M. Pogach Pharmacy Costs and Glycemic Control in the Department of Veterans Affairs Diabetes Care, May 1, 2004; 27(suppl_2): B74 - B81. [Abstract] [Full Text] [PDF]

				C. T. Sawin, D. J. Walder, D. S. Bross, and L. M. Pogach Diabetes Process and Outcome Measures in the Department of Veterans Affairs Diabetes Care, May 1, 2004; 27(suppl_2): B90 - B94. [Abstract] [Full Text] [PDF]

				T. N. Patel and K. C. Goldberg Use of Aspirin and Ibuprofen Compared With Aspirin Alone and the Risk of Myocardial Infarction Arch Intern Med, April 26, 2004; 164(8): 852 - 856. [Abstract] [Full Text] [PDF]

				D. A. Helmer, C.-L. Tseng, M. Brimacombe, M. Rajan, N. Stiptzarov, and L. Pogach Applying Diabetes-Related Prevention Quality Indicators to a National Cohort of Veterans With Diabetes Diabetes Care, November 1, 2003; 26(11): 3017 - 3023. [Abstract] [Full Text] [PDF]

				E. A. Kerr, D. M. Smith, S. H. Kaplan, and R. A. Hayward The Association between Three Different Measures of Health Status and Satisfaction among Patients with Diabetes Med Care Res Rev, June 1, 2003; 60(2): 158 - 177. [Abstract] [PDF]

				G. D. Schiff, D. Klass, J. Peterson, G. Shah, and D. W. Bates Linking Laboratory and Pharmacy: Opportunities for Reducing Errors and Improving Care Arch Intern Med, April 28, 2003; 163(8): 893 - 900. [Abstract] [Full Text] [PDF]

				M. Safford, L. Eaton, G. Hawley, M. Brimacombe, M. Rajan, H. Li, and L. Pogach Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus Arch Intern Med, April 28, 2003; 163(8): 922 - 928. [Abstract] [Full Text] [PDF]

				M. Heisler, D. M. Smith, R. A. Hayward, S. L. Krein, and E. A. Kerr How Well Do Patients' Assessments of Their Diabetes Self-Management Correlate With Actual Glycemic Control and Receipt of Recommended Diabetes Services? Diabetes Care, March 1, 2003; 26(3): 738 - 743. [Abstract] [Full Text] [PDF]

				S. L. Krein, S. Vijan, L. M. Pogach, M. M. Hogan, and E. A. Kerr Aspirin Use and Counseling About Aspirin Among Patients With Diabetes Diabetes Care, June 1, 2002; 25(6): 965 - 970. [Abstract] [Full Text] [PDF]

				R. E. Glasgow, R. G. Hiss, R. M. Anderson, N. M. Friedman, R. A. Hayward, D. G. Marrero, C. B. Taylor, and F. Vinicor Report of the Health Care Delivery Work Group: Behavioral research related to the establishment of a chronic disease model for diabetes care Diabetes Care, January 1, 2001; 24(1): 124 - 130. [Abstract] [Full Text]